Clinical trial
Effect of Prasugrel on Platelets After One Week in Patients Already Taking…
NCT00356135 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00356135 |
|---|---|
| Title | Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event |
| Official title | A Pharmacodynamic Comparison of Prasugrel (LY640315) Versus Clopidogrel in Subjects With Acute Coronary Syndrome Who Are Receiving Clopidogrel |
| Acronym | SWAP |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Daiichi Sankyo Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Arteriosclerosis, Acute Coronary Syndrome |
| Intervention type | Drug |
| Interventions | prasugrel 10 mg, clopidogrel, prasugrel placebo, prasugrel 60 mg, clopidogrel placebo |
| Enrollment | 139 |
| Start date | Jul 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jul 25, 2006 |
| Last update posted | Nov 3, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: